News
Statin may reduce vaso-occlusive pain in SCD
- Author:
- Jen Smith
Photo courtesy of the CDC ORLANDO, FL—In a small study, the cholesterol-lowering medication simvastatin reduced the frequency of vaso-occlusive...
News
Graft source and timing of HSCT affect survival in SCD
- Author:
- Jen Smith
Photo by Chad McNeeley ORLANDO, FL—In a large, registry-based study, transplants from human leukocyte antigen (HLA)-identical sibling donors...
News
CAR T-cell therapy dubbed ‘promising’ for MM
- Author:
- Jen Smith
Photo courtesy of ASH ORLANDO, FL—Chimeric antigen receptor (CAR) T cells can have “powerful activity” in patients with multiple myeloma (MM),...
News
HU noninferior to transfusion for stroke prevention in SCD
- Author:
- Jen Smith
Photo courtesy of ASH ORLANDO, FL—Hydroxyurea (HU) is noninferior to chronic blood transfusions for reducing the risk of stroke in children with...
News
Combination offers ‘important new option’ for CLL, team says
- Author:
- Jen Smith
Photo courtesy of ASH ORLANDO, FL—Idelalisib, the first-in-class PI3Kδ inhibitor, combined with bendamustine and rituximab (BR) for relapsed/...
News
Triplet disappoints in follicular lymphoma trial
- Author:
- Jen Smith
Photo courtesy of ASH ORLANDO, FL—A 3-drug regimen is likely not worth pursuing as a first-line treatment option for follicular lymphoma (FL),...
News
Source of FVIII replacement matters, study shows
- Author:
- Jen Smith
Photo courtesy of ASH ORLANDO, FL—The source of factor VIII (FVIII) replacement therapy affects the risk of inhibitor development in previously...
News
mAb could provide targeted approach to HLH treatment
- Author:
- Jen Smith
ASH Annual Meeting Photo courtesy of ASH ORLANDO, FL—A monoclonal antibody (mAb) targeting interferon-gamma (IFNγ) has shown promise for treating...
News
CAR exhibits activity in resistant B-cell malignancies
- Author:
- Jen Smith
Photo courtesy of ASH ORLANDO, FL—Allogeneic chimeric antigen receptor (CAR) T cells directed against CD19 can have “significant” activity...
News
Ibrutinib ‘treatment of choice’ in rel/ref MCL
- Author:
- Jen Smith
Annual Meeting Photo courtesy of ASH ORLANDO, FL—The BTK inhibitor ibrutinib should be considered the treatment of choice for patients with...
News
Timing of irradiation affects RCCs
- Author:
- Jen Smith
ANAHEIM, CA—The timing of gamma irradiation influences in vitro characteristics of red cell concentrates (RCCs), according to a new study. The...
News
Newer apheresis system appears superior to standard
- Author:
- Jen Smith
Photo by ec-jpr ANAHEIM, CA—A newer, more streamlined apheresis system yields more CD34+ cells from stem cell transplant donors than a previous...
News
Survey: 3 in 10 MSMs don’t comply with UK blood donor policy
- Author:
- Jen Smith
Photo by Marja Helander ANAHEIM—A survey of UK blood donors suggests that as many as 30% of donors who are men who have sex with men (MSM) may...
News
Interventions can treat, prevent iron deficiency in blood donors
- Author:
- Jen Smith
ANAHEIM, CA—Data from the STRIDE study have revealed interventions that can mitigate iron deficiency in repeat blood donors. The study showed...
News
Assay can detect and classify DOACs
- Author:
- Jen Smith
Photo by Juan D.